Moloney Securities Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,278
| Closed | -$205K | – | 520 |
|
|
2024
Q4 | $205K | Sell |
2,278
-55
| -2% | -$4.95K | 0.03% | 413 |
|
|
2024
Q3 | $230K | Sell |
2,333
-274
| -11% | -$27.1K | 0.03% | 413 |
|
|
2024
Q2 | $242K | Buy |
+2,607
| New | +$242K | 0.03% | 390 |
|
|
2022
Q1 | – | Sell |
-2,146
| Closed | -$240K | – | 464 |
|
|
2021
Q4 | $240K | Sell |
2,146
-27
| -1% | -$3.02K | 0.04% | 371 |
|
|
2021
Q3 | $273K | Hold |
2,173
| – | – | 0.05% | 340 |
|
|
2021
Q2 | $294K | Sell |
2,173
-9
| -0.4% | -$1.22K | 0.05% | 327 |
|
|
2021
Q1 | $296K | Sell |
2,182
-360
| -14% | -$48.8K | 0.06% | 309 |
|
|
2020
Q4 | $358K | Sell |
2,542
-2,173
| -46% | -$306K | 0.08% | 251 |
|
|
2020
Q3 | $525K | Sell |
4,715
-3,569
| -43% | -$397K | 0.14% | 162 |
|
|
2020
Q2 | $927K | Buy |
+8,284
| New | +$927K | 0.27% | 103 |
|
|
2020
Q1 | – | Sell |
-2,164
| Closed | -$206K | – | 360 |
|
|
2019
Q4 | $206K | Buy |
+2,164
| New | +$206K | 0.06% | 321 |
|
|
2019
Q3 | – | Sell |
-2,368
| Closed | -$208K | – | 358 |
|
|
2019
Q2 | $208K | Sell |
2,368
-90
| -4% | -$7.91K | 0.07% | 283 |
|
|
2019
Q1 | $223K | Buy |
+2,458
| New | +$223K | 0.08% | 259 |
|
|
2018
Q4 | – | Sell |
-2,358
| Closed | -$226K | – | 314 |
|
|
2018
Q3 | $226K | Hold |
2,358
| – | – | 0.08% | 254 |
|
|
2018
Q2 | $224K | Hold |
2,358
| – | – | 0.09% | 253 |
|
|
2018
Q1 | $207K | Sell |
2,358
-42
| -2% | -$3.69K | 0.08% | 263 |
|
|
2017
Q4 | $204K | Sell |
2,400
-840
| -26% | -$71.4K | 0.09% | 240 |
|
|
2017
Q3 | $280K | Buy |
+3,240
| New | +$280K | 0.12% | 194 |
|
|
2017
Q2 | – | Sell |
-3,517
| Closed | -$244K | – | 261 |
|
|
2017
Q1 | $244K | Buy |
3,517
+101
| +3% | +$7.01K | 0.13% | 200 |
|
|
2016
Q4 | $202K | Buy |
+3,416
| New | +$202K | 0.12% | 194 |
|